Clinical Trials Logo

Metastatic Cancer clinical trials

View clinical trials related to Metastatic Cancer.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT05162443 Approved for marketing - Metastatic Cancer Clinical Trials

Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation

Start date: n/a
Phase:
Study type: Expanded Access

The objective of this EAP is to provide expanded access of adagrasib (MRTX849) to patients with previously treated advanced solid tumors harboring a KRAS G12C mutation.